(Q34325532)

1 August 2017

Identification of REPS2 as a putative modulator of NF-kappaB activity in prostate cancer cells (English)

1 reference

1 August 2017

0 references

1 reference

Fred Penninkhof

1

1 reference

1 August 2017

J Anton Grootegoed

series ordinal

2

1 reference

1 August 2017

Leen J Blok

series ordinal

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

1 August 2017

1 reference

1 August 2017

23

1 reference

1 August 2017

33

1 reference

1 August 2017

5607-5615

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207750

1 August 2017

0 references

cites work

Molecular mechanism of NPF recognition by EH domains

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

Identification and characterization of a novel protein interacting with Ral-binding protein 1, a putative effector protein of Ral

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

A protein-binding domain, EH, identified in the receptor tyrosine kinase substrate Eps15 and conserved in evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

NF-kappa B activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

Structure and Asn-Pro-Phe binding pocket of the Eps15 homology domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

eps15, a novel tyrosine kinase substrate, exhibits transforming activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

Nuclear transcription factor-kappaB as a target for cancer drug development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

Structure of an IkappaBalpha/NF-kappaB complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

Propapoptotic effects of NF-kappaB in LNCaP prostate cancer cells lead to serine protease activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

REPS2/POB1 is downregulated during human prostate cancer progression and inhibits growth factor signalling in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

Recognition specificity of individual EH domains of mammals and yeast

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

Binding specificity and in vivo targets of the EH domain, a novel protein-protein interaction module

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207750

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207750

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference